ConocoPhillips vs MPLX LP — Stock Comparison
Q·Score Breakdown
6.5
Neutral
Overall
7
Bullish
Quality
Health
Growth
Valuation
Sentiment
COP
Clean balance sheet with low leverage (0.4× debt-to-equity).
⚠ revenue declining 5% year-over-year.
MPLX
High-quality business with 35% return on equity and 42% profit margins.
⚠ balance sheet warrants attention.
Analyst Consensus
BUY
Target $140.37 (+13.9%)
27 analysts
HOLD
Target $60.64 (+7.1%)
14 analysts
Fundamentals
COP
MPLX
20.9×
Trailing P/E
11.7×
14.5×
Forward P/E
11.5×
12.3%
Profit Margin
41.6%
45.6%
Gross Margin
56.7%
11.3%
ROE
34.7%
-5.3%
Revenue Growth
7.1%
-20.2%
Earnings Growth
9.1%
0.19
Beta
0.54
—
Price / Book
—
$150.1B
Market Cap
$57.5B
$84 – $136
52-Week Range
$48 – $60
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →